A detailed history of Brewin Dolphin Wealth Management LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 132 shares of EW stock, worth $8,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
132
Holding current value
$8,944
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Nov 14, 2022

BUY
$86.5 - $128.27 $11,418 - $16,931
132 New
132 $13,000
Q1 2022

Nov 14, 2022

SELL
$101.96 - $128.34 $30,587 - $38,502
-300 Closed
0 $0
Q4 2021

Nov 14, 2022

BUY
$106.37 - $130.68 $31,911 - $39,204
300 New
300 $39,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.